Biomea Fusion announces pricing of public offering of securities

* Biomea Fusion (NASDAQ:BMEA [https://seekingalpha.com/symbol/BMEA]) announced the pricing of its public offering for gross proceeds of $25 million.
* The offer consists of 11.19M shares of its common stock and accompanying warrants to purchase an aggregate of 11.19M shares of common stock. In lieu of common stock, the company will offer to certain investors, pre-funded warrants to purchase an aggregate of up to 1M shares of its common stock and accompanying warrants to purchase an aggregate of up to 1M shares of common stock (or pre-funded warrants in lieu thereof), at an exercise price of $0.0001 per pre-funded warrant.
* In addition, Biomea has granted the underwriters a 30-day option to purchase up to an additional 1,829,268 shares of common stock and/or warrants to purchase 1,829,268 shares of common stock at the public offering price, less underwriting discounts and commissions. The common stock and pre-funded warrants are being sold in combination with an accompanying warrant to purchase one share of common stock (or a pre-funded warrant in lieu thereof) issued for each share of common stock or pre-funded warrant sold. The accompanying warrant has an exercise price of $2.50 per share, is immediately exercisable from the date of issuance and will expire three years from the date of issuance.
* The combined offering price of each share of common stock and accompanying common stock warrant is $2.05. The combined offering price of each pre-funded warrant and accompanying common stock warrant is $2.0499.
* The offering is expected to close on October 8, 2025, subject to the satisfaction of customary closing conditions.
* BMEA --25.4% premarket to $1.99.
* Source: Press Release [https://seekingalpha.com/pr/20256753-biomea-fusion-announces-pricing-of-public-offering-of-securities]

MORE ON BIOMEA FUSION

* Biomea Fusion rises after results from type 2 diabetes drug [https://seekingalpha.com/news/4502129-biomea-fusion-rises-after-results-from-type-2-diabetes-drug]
* Seeking Alpha’s Quant Rating on Biomea Fusion [https://seekingalpha.com/symbol/BMEA/ratings/quant-ratings]
* Historical earnings data for Biomea Fusion [https://seekingalpha.com/symbol/BMEA/earnings]
* Financial information for Biomea Fusion [https://seekingalpha.com/symbol/BMEA/income-statement]